d-ribose-l-cysteine 1561 views0 applications

Australian Approved Name (AAN): d-ribose-l-cysteine

Common name/s and synonyms: 2-(1,2,3,4-Tetrahydroxybutyl)thiazolidine-4-carboxylic acid

Maximum daily dose: The medicine must provide no more than 450mg of cysteine per maximum recommended daily dose.

Mandatory components: Cysteine

Warnings and restrictions: Only for use in oral medicines.

Allowable purpose of the ingredient: Active

TGA reference: CHEMID plus (National Library of Medicine)

Apply for this resource
Share this resource